StockData
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT) stock

NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.11−1.13 (-5.58%)

Close on Nov 16, 2026Market cap $622.63MP/E –Yield 0.00%

Nuvectis Pharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Nuvectis Pharma

Nuvectis Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Nuvectis Pharma figures

See a number that looks wrong?